14.04.2014 11:34:00

Arkema : Information Relating to the Combined Annual General Meeting of 15Th May 2014

Regulatory News:

The shareholders of Arkema (Paris:AKE) are invited to participate to the Combined Annual General Meeting (ordinary and extraordinary) which will take place on 15th May 2013 at 10.30 am (Paris time) at the Palais des Congrès, Amphithéâtre bleu, 2 place de la Porte Maillot, 75017 Paris.

The information provided for in article R.225-73 of the French Commercial Code including the Preliminary Notice of Meeting (Avis de réunion - only available in French) published in the BALO (Bulletin des Annonces Légales et Obligatoires) dated 5th March 2014, the Notice of Meeting (Avis de convocation - only available in French) published in the BALO dated 14th April 2014, the Notice of Meeting leaflet as well as the terms of participation and vote to this Annual General Meeting are available in the section « Shareholders & Investors » of the Group’s website, under the following link: www.finance.arkema.com.

The information provided for in article R.225-83 of the French Commercial Code is included in the 2013 Reference Document, also available on the aforesaid website.

These documents are also available to the shareholders at Arkema’s headquarters.

A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generates annual revenue of €6.1 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.

ARKEMA
420, rue d’Estienne d’Orves – F-92705 COLOMBES Cedex – France
Standard : +33 (0)1 49 00 80 80 – Fax : +33 (0)1 49 00 83 96
Société anonyme au capital de 630 296 920 euros – 445 074 685 RCS Nanterre

Analysen zu ArkemaAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ArkemaAct. 74,15 -1,20% ArkemaAct.